BUSINESS

Moderna shares plunge after leak of cancer vaccine data despite positive results

CNBC BusinessThursday, October 22, 2026 at 7:26 PM

RedScroll Brief

Moderna's stock fell even though the full data, released later Thursday, appeared positive based on Wall Street expectations ahead of the release.

RedScroll Signal

Impact: High
Category: Business
Market relevance: High
Why it matters: Corporate and market moves reprice risk and reveal where power and cash are concentrating. Moderna's stock fell even though the full data, released later Thursday, appeared positive based on Wall Street expectations ahead of the release. Investors will watch earnings, rates, and competitive positioning connected to Moderna and Business.

Read original source → CNBC BUSINESS Edition 2026-10-22

Desk copy

RedScroll Briefing

Extractive editorial brief — not a reprint of the original

What happened

Moderna's stock fell even though the full data, released later Thursday, appeared positive based on Wall Street expectations ahead of the release.

Why it matters

Corporate and market moves reprice risk and reveal where power and cash are concentrating.

Background

CNBC Business reported on this under business. RedScroll surfaces the signal with an extractive brief — not a reprint of the original article. Read the source for full reporting.

Timeline

Thu, Oct 22, 2026, 7:26 PM UTC
CNBC Business published: Moderna shares plunge after leak of cancer vaccine data despite positive results
Now
Story is in today’s RedScroll edition. Follow the original source for updates.

Economic impact

Investors will watch earnings, rates, and competitive positioning connected to Moderna and Business.

Source

CNBC Business

Original reporting by CNBC Business. RedScroll provides an extractive briefing only.